| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +45.45% | -1.41% | +1.44% | -2.85% | -1.93% | — |
| 14d | 11 | +72.73% | -6.63% | -0.01% | -6.62% | -8.66% | — |
| 30d | 11 | +63.64% | -6.20% | +3.09% | -9.29% | -10.37% | — |
| 60d | 11 | +63.64% | +8.54% | +7.20% | +1.35% | -8.35% | — |
| 90d | 11 | +36.36% | +18.26% | +11.16% | +7.10% | +0.58% | — |
| 180d | 11 | +63.64% | +11.14% | +19.66% | -8.52% | -33.85% | — |
| 1y | 11 | +63.64% | -16.23% | +31.30% | -47.53% | -70.38% | — |
| 2y | 11 | +100.00% | -67.03% | +18.79% | -85.82% | -90.73% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 5,195 | $0.60 | $3.1K | 26,546 | Mar 2, 2021 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 2,295 | $62.46 | $143.4K | 24,251 | Mar 2, 2021 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,800 | — | — | 40,800 | Mar 2, 2021 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 5,195 | — | — | 82,874 | Mar 2, 2021 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 2,900 | $63.52 | $184.2K | 21,351 | Mar 2, 2021 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 8,000 | — | — | 88,069 | Dec 28, 2020 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 149 | $58.73 | $8.8K | 21,351 | Dec 28, 2020 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 8,000 | $0.60 | $4.8K | 21,500 | Dec 28, 2020 | Mar 4, 2021 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 1,503 | $2.19 | $3.3K | 45,500 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 7,225 | $38.42 | $277.6K | 13,500 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 30,497 | — | — | 96,069 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 30,497 | $0.60 | $18.3K | 43,997 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 24,775 | $37.64 | $932.6K | 20,725 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 1,503 | — | — | 70,386 | Oct 19, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 5,851 | $0.60 | $3.5K | 19,351 | Oct 16, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 5,851 | — | — | 126,566 | Oct 16, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 5,851 | $40.00 | $234.0K | 13,500 | Oct 16, 2020 | Oct 20, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 1,649 | $40.00 | $66.0K | 13,500 | Oct 13, 2020 | Oct 13, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 1,649 | — | — | 132,417 | Oct 13, 2020 | Oct 13, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 1,649 | $0.60 | $989 | 15,149 | Oct 13, 2020 | Oct 13, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 10,895 | $25.82 | $281.3K | 22,605 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 7,875 | $26.91 | $211.9K | 14,730 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 20,000 | $2.19 | $43.8K | 33,500 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 1,230 | $27.48 | $33.8K | 13,500 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 20,000 | — | — | 71,889 | Jun 1, 2020 | Jun 3, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 7,500 | $0.60 | $4.5K | 21,000 | May 22, 2020 | May 26, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 7,500 | $30.00 | $225.0K | 13,500 | May 22, 2020 | May 26, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 7,500 | — | — | 134,066 | May 22, 2020 | May 26, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 7,500 | — | — | 141,566 | Mar 31, 2020 | Apr 15, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 7,500 | $0.60 | $4.5K | 13,500 | Mar 31, 2020 | Apr 15, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 7,500 | — | — | 141,566 | Mar 31, 2020 | May 26, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,000 | — | — | 42,000 | Mar 25, 2020 | Mar 26, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 6,000 | — | — | 149,066 | Dec 20, 2019 | Apr 15, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE EVP Research & Preclinical Dev | 6,000 | $0.60 | $3.6K | 6,000 | Dec 20, 2019 | Apr 15, 2020 ↗ |
| STOK STOKE THERAPEUTICS, INC. | SALE EVP Research & Preclinical Dev | 6,000 | — | — | 149,066 | Dec 20, 2019 | May 26, 2020 ↗ |